Breast Thermography testing is a radiation-free screening procedure that captures heat images of the breast to aid in the early detection of cancer and fibrocystic breast disease. As a tumor grows it develops a blood supply that emits heat that is detected on a modern infrared device as seen in the photo. Thermography can establish overall breast health and is an excellent test for assessing fibrocystic breasts and response to treatment. Thermography works great as a part of a multi-modal approach.
Breast Cancer Found with Breast Thermography Testing
In the photo example, the heat associated from Angioneogenesis is seen in the right nipple region. The patient was diagnosed with a 2.4 cm tumor behind the right nipple after breast thermography screening. She had been for several mammograms that had missed this. According to the www.cancer.gov mammography misses up to 20% of tumors overall, and is ineffective statistically in women with dense breasts. Breast thermography can be used with women with dense breasts and women under 40 years of age.
Breast Thermography Testing and The FDA
The Food and Drug Administration has cleared thermography for several purposes as an adjunctive screening. One of these is breast cancer screening. It is important to understand that breast thermography is not a stand alone procedure for breast cancer screening.
The FDA stance is a valid one, and one that we have embraced. We believe that the more information in the quest for the early detection we have, the more cases we will find. The November 2012 article in the New England Journal of Medicine brought this fact to light. Mammograms have failed to reduce fatalities in cancer across a population base as a sole method of screening. We would like to see research in the area of combining non radiation tests (MRI, Ultrasound, Thermography). It would be simple to incorporate thermography and ultrasound, or thermography and MRI.